strategic alliance, page-30

Thank you for posting this Pman,

Where does the pharmaceutical news of a multi billion dollar drug in consumer acceptance testing fit in?


-GSK obviously announced its healthcare development with one of the FIM applications in a 29 billion dollar market.

-The new FMCG has announced the Strategic Alliance eyeing both, the micro array and the FIM technology, with declared emphasis on nonpharmaceutical developments though.
There would not have been enough time though to conclude the lengthy testing cycles necessary for pharmaceutical products and drug deliveries as they have entered the spotlight recently.
They are targeting a " wide range " of products, this is potentially huge ( still stunned about market reaction regarding this ann )

-The original FMCG, in my opinion, is at this point in time the most likely candidate for the multi billion drug as they had over 2 years time to go through all the testing regime.

-Alternatively GSK could have started drug testing in 2006, surprising though that they would seperate their partnering announcement with OBJ into a FIM application related and a to be later announced em-Patch related publication.


The em-Patch component is the missing link in the 2 latest announcements and we, most likely, will see an ann regarding this as soon as consumer acceptance testing will have run its course.
This ann should have, if testing is concluded positively, a licence deal with advance payment attached.

Here a calendar of anns to be expected shortly:
-Offical confirmation of the Strategic Alliance and revealing of company name with the second FMCG after finalising technical evaluation

- Results of consumer acceptance testing for one multi billion dollar drug ( most likely involing our em-patch ), possibly of our first FMCG. Revelation of name of company.


Very interesting times ahead with the surprising update and development launch of FIM applied products with the GSK giving us plenty of back wind moving north.

On another note, most intruiging to see our 12mil seller up again at 2.3 cents. This indeed can not be a disgruntled holder ( on what grounds would one be possible still be disgruntled ), this is almost guaranteed further manipulation of holding a shareprice down of a company which is about to be rerated.